Literature DB >> 19588217

Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome.

Atsushi Isoda1, Atsushi Sakurai2, Yoshiyuki Ogawa3, Yuri Miyazawa3, Akio Saito3, Morio Matsumoto3, Morio Sawamura3.   

Abstract

Paraneoplastic neuropathies have rarely been reported in patients with hematological malignancies. We report herein the case of a 65-year-old Japanese woman with chronic myelomonocytic leukemia (CMML) accompanying chronic inflammatory demyelinating polyneuropathy (CIDP). She had been diagnosed with refractory anemia and subsequently developed CMML with cytogenetic abnormalities including t(3;8)(q26;q24). While regenerating bone marrow following induction chemotherapy, she complained of numbness in the lower legs and then became unable to walk. Clinical and electrophysiological features were consistent with CIDP. Intravenous immunoglobulin treatment was insufficient, although corticosteroids reduced neurological symptoms. This case suggests CIDP as one of the autoimmune phenomena associated with myelodysplastic syndrome and immunosuppressive treatment represents an effective therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19588217     DOI: 10.1007/s12185-009-0375-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  8 in total

1.  European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.

Authors: 
Journal:  J Peripher Nerv Syst       Date:  2005-09       Impact factor: 3.494

Review 2.  Immunological abnormalities in myelodysplastic syndromes.

Authors:  T J Hamblin
Journal:  Semin Hematol       Date:  1996-04       Impact factor: 3.851

3.  Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease.

Authors:  Sa A Wang; Naomi Galili; Jan Cerny; Eric Sechman; Su Sin Chen; Jerome Loew; Qin Liu; Oluwole Fadare; Robert Hasserjian; Dan Jones; Huma Qawi; Bruce Woda; Azra Raza
Journal:  Am J Clin Pathol       Date:  2006-11       Impact factor: 2.493

4.  Chronic myelomonocytic leukemia: natural history and prognostic determinants.

Authors:  A Tefferi; H C Hoagland; T M Therneau; R V Pierre
Journal:  Mayo Clin Proc       Date:  1989-10       Impact factor: 7.616

5.  Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.

Authors:  Pei Lin; L Jeffrey Medeiros; C Cameron Yin; Lynne V Abruzzo
Journal:  Cancer Genet Cytogenet       Date:  2006-04-01

Review 6.  Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.

Authors:  Muhammad Wasif Saif; Jon L Hopkins; Steven D Gore
Journal:  Leuk Lymphoma       Date:  2002-11

7.  Immune-mediated complications in patients with myelodysplastic syndromes--clinical and cytogenetic features.

Authors:  R Billström; H Johansson; B Johansson; F Mitelman
Journal:  Eur J Haematol       Date:  1995-07       Impact factor: 2.997

8.  Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy.

Authors:  H Enright; H S Jacob; G Vercellotti; R Howe; M Belzer; W Miller
Journal:  Br J Haematol       Date:  1995-10       Impact factor: 6.998

  8 in total
  4 in total

1.  Therapy-related myelodysplastic syndrome: a case study.

Authors:  Masahiro Manabe; Katsuya Wada; Dai Momose; Yasuyoshi Sugano; Masayuki Hino; Takahisa Yamane; Eiwa Ishida; Ki-Ryang Koh
Journal:  Am J Blood Res       Date:  2015-12-25

2.  The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations.

Authors:  Anca Franzini; Anthony D Pomicter; Dongqing Yan; Jamshid S Khorashad; Srinivas K Tantravahi; Hein Than; Jonathan M Ahmann; Thomas O'Hare; Michael W Deininger
Journal:  Blood Adv       Date:  2019-10-22

Review 3.  Myelodysplastic syndromes and autoimmune diseases--case series and review of literature.

Authors:  Omar Al Ustwani; Laurie A Ford; Sheila J N Sait; Anne Marie W Block; Maurice Barcos; Carlos E Vigil; Elizabeth A Griffiths; James E Thompson; Eunice S Wang; Julian Ambrus; Meir Wetzler
Journal:  Leuk Res       Date:  2013-05-18       Impact factor: 3.156

4.  Expressive aphasia in a patient with chronic myelomonocytic leukemia.

Authors:  Darwin F Yeung; Rose Hsu
Journal:  Springerplus       Date:  2014-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.